About Us公司簡介

博惠生技股份有限公司隸屬於GICC集團，是一家專注於生物科技與醫療服務的公司。在創辦人精神的引領下，公司秉持「創新突破，尋求解方」的理念，致力於推動醫療科技的發展。

公司的核心業務領域包括：

1.細胞治療技術應用與優化：引進日本先進的HITV免疫細胞治療技術，在癌症治療方面展現顯著療效。
2.外泌體應用與開發：利用專業GTP實驗室，研發高濃度、專業化的外泌體產品。
3.新藥開發：專注於癌症藥物研究，致力於提供有效的癌症預防與治療方案。

Bo Hui Biotech Co., Ltd. is a biotechnology and medical services company under the GICC Group. Guided by the founder’s spirit, the company operates with the philosophy of “Innovation and Breakthroughs to Seek Solutions.”
The company’s core business areas include:
1) Cell Therapy Technology Application and Optimization: Introducing Japan’s cutting-edge HITV immune cell therapy, which has demonstrated significant efficacy in cancer treatment.
2) Exosome Application and Development: Utilizing a professional GTP laboratory to develop high-concentration, specialized exosomes.
3) New Drug Development: Focusing on cancer drug research to provide effective solutions for cancer prevention and treatment.